OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

Ferroptosis inhibitors: past, present and future
Lei Zhang, Yi Luo, Yang Xiang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 17

Novel Role of the SIRT1 in Endocrine and Metabolic Diseases
Chenxi Lu, Huadong Zhao, Yanqing Liu, et al.
International Journal of Biological Sciences (2022) Vol. 19, Iss. 2, pp. 484-501
Open Access | Times Cited: 63

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease
Defeng Li, Meifeng Yang, Jing Xu, et al.
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 3893-3911
Open Access | Times Cited: 39

Immunopathogenesis and immunotherapy of diabetes-associated periodontitis
Shuangshuang Li, Shuang Li, Lingxiao Meng, et al.
Clinical Oral Investigations (2025) Vol. 29, Iss. 1
Closed Access | Times Cited: 1

Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways
Halyna Tkachenko, Natalia Kurhaluk
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1098-1098
Open Access | Times Cited: 1

Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
Wiebe M. C. Top, Adriaan Kooy, Coen D.A. Stehouwer
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 312-312
Open Access | Times Cited: 32

Diabetes and its Complications
Simon Matoori
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 8, pp. 513-515
Open Access | Times Cited: 32

Senescent cardiac fibroblasts: A key role in cardiac fibrosis
José Miguel Osorio, Claudio Espinoza-Pérez, Constanza Rimassa-Taré, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 4, pp. 166642-166642
Open Access | Times Cited: 21

The Effect of Metformin on Chemotherapy-Induced Toxicities in Non-diabetic Breast Cancer Patients: A Randomised Controlled Study
Manar A. Serageldin, Amira B. Kassem, Yasser Elkerm, et al.
Drug Safety (2023) Vol. 46, Iss. 6, pp. 587-599
Open Access | Times Cited: 20

Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer
Chengmin Deng, Lin Xiong, Yang Chen, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 16

Sirtuin dysregulation in Parkinson's disease: Implications of acetylation and deacetylation processes
Sonia Dhiman, Ashi Mannan, Ayushi Taneja, et al.
Life Sciences (2024) Vol. 342, pp. 122537-122537
Closed Access | Times Cited: 7

Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways
Mohammad Yasin Zamanian, Maryam Golmohammadi, Alexey Yumashev, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 4
Open Access | Times Cited: 7

Metformin alleviates junctional epithelium senescence via the AMPK/SIRT1/autophagy pathway in periodontitis induced by hyperglycemia
Xiaoyuan Ye, Yumin Wang, Yanying Tian, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27478-e27478
Open Access | Times Cited: 6

The Regulation of the AMPK/mTOR Axis Mitigates Tendon Stem/Progenitor Cell Senescence and Delays Tendon Aging
Guangchun Dai, Yingjuan Li, Ming Zhang, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 5, pp. 1492-1506
Closed Access | Times Cited: 13

Metformin improves cognitive dysfunction through SIRT1/NLRP3 pathway–mediated neuroinflammation in db/db mice
Hu Tian, Jun-Wen Wei, Jiayi Zheng, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 9, pp. 1101-1115
Closed Access | Times Cited: 5

Modulation of M1 and M2 macrophage polarization by metformin: Implications for inflammatory diseases and malignant tumors
Sara Jafarzadeh, Maryam Nemati, Raziyeh Zandvakili, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114345-114345
Closed Access

Senotherapeutics: Milestones, innovations, and future prospects
Erdem Atasever, Mehmet Can Atayik, Ufuk Çakatay
Advances in pharmacology (2025)
Closed Access

Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health
Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Metformin attenuates diabetic osteoporosis by suppressing ferroptosis via the AMPK/Nrf2 pathway
Yanwei Liu, Zhaoyu Fu, Xiaoyi Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Metformin use and risk of total joint replacement in patients with diabetes: a longitudinal cohort study of Alberta’s Tomorrow Project
Ming Ye, Jennifer E. Vena, Grace Shen‐Tu, et al.
BMC Musculoskeletal Disorders (2025) Vol. 26, Iss. 1
Open Access

A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer
Elaine Chow, Aimin Yang, Colin Ho Lam Chung, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 442-442
Open Access | Times Cited: 22

Protection by metformin against severe Covid-19: An in-depth mechanistic analysis
Nicolas Wiernsperger, Abdallah Al‐Salameh, Bertrand Cariou, et al.
Diabetes & Metabolism (2022) Vol. 48, Iss. 4, pp. 101359-101359
Open Access | Times Cited: 21

Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms
Noa Hurvitz, Narmine Elkhateeb, Tal Sigawi, et al.
Frontiers in Aging (2022) Vol. 3
Open Access | Times Cited: 20

Page 1 - Next Page

Scroll to top